Baker McKenzie’s Corporate team has advised Sofinnova Partners and Asabys Partners on a 12 million euros investment round in Barcelona-based biotech Nuage Therapeutics. The company plans to use the proceeds of the deal to initiate
Baker McKenzie’s Corporate team has advised Sofinnova Partners and Asabys Partners on a 12 million euros investment round in Barcelona-based biotech Nuage Therapeutics. The company plans to use the proceeds of the deal to initiate